G1 Therapeutics, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019
License revenue
Revenues
Product sales, net
License revenue
Total revenues
Operating Expenses
Cost of goods sold
Research and development
Selling, general and administrative
Total operating expenses
Loss from operations
Other income (expense)
Other income
Interest income
Interest expense
Other income (expense)
Total other income (expense), net

Loss before income taxes
Income tax expense
Net loss
Net loss attributable to common stockholders
Net loss per share, basic and diluted
Weighted average common shares outstanding, basic and diluted
Earnings Per Share
Basic (in usd per share)
Diluted (in usd per share)
Weighted Average Common Shares Outstanding
Basic (in shares)
Diluted (in shares)

Comments